I honestly believe management needs to pull their finger out. There was very minimal mentioning of the pathway to FDA approval in the latest quarterly. They seem to be more focused on Aussie sales than gaining approval in the US. FDA approval should be the ONLY thing they are concerned about right now.
LTP Price at posting:
$1.19 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)